Stadovas 10 Tab.

Rx

Indications:

Hypertension.

Chronic stable angina pectoris.

Vasospastic (Prinzmetal’s) angina.

Dosage:

• Adults: For both hypertension (in combination with a thiazide diuretic, alpha blocker, beta blocker, or an angiotensin converting enzyme inhibitor) and angina (monotherapy or in combination with other anti-anginal medicinal products in patients with angina that is refractory to nitrates and/or to adequate doses of beta blockers), the initial dose is 5 mg amlodipine once daily which may be increased to a maximum dose of 10 mg depending on the individual patient’s response.
• Children with hypertension from 6 – 17 years of age: The starting dose is 2.5 mg once daily (using other suitable preparation), up-titrated to 5 mg once daily if blood pressure goal is not achieved after 4 weeks.
• Elderly: Increase of the dosage should take place with care.
• Hepatic impairment: Start at the lower end of the dosing range. Amlodipine should be titrated slowly and monitor closely in patients with severe hepatic impairment.
• Renal impairment: Normal dosage is recommended.

Usage:

Stadovas 10 Tab. is administered orally.

Hypersensitivity to any of components of the drug or dihydropyridine derivatives.

Severe hypotension.

Shock (including cardiogenic shock).

Obstruction of the outflow tract of the left ventricle.

Haemodynamically unstable heart failure after acute myocardial infarction.

Most common: Headaches, dizziness, somnolence; palpitations; flushing; abdominal pain, nausea; oedema, fatigue.

Patients with heart failure.

Patients with impaired hepatic function.

Pregnancy (only use when there is no safer alternative and when the disease itself carries greater risk). Account the benefit of breast-feeding to the child and therapy to the mother.